5-6633782-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001324323.2(SRD5A1):c.-516A>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000939 in 1,597,616 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001324323.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRD5A1 | ENST00000274192.7 | c.206A>G | p.Tyr69Cys | missense_variant | Exon 1 of 5 | 1 | NM_001047.4 | ENSP00000274192.5 | ||
SRD5A1 | ENST00000504286.1 | n.327A>G | non_coding_transcript_exon_variant | Exon 1 of 3 | 2 | ENSP00000518753.1 | ||||
SRD5A1 | ENST00000510531.5 | n.206A>G | non_coding_transcript_exon_variant | Exon 1 of 6 | 2 | ENSP00000425330.1 | ||||
SRD5A1 | ENST00000513117.1 | n.206A>G | non_coding_transcript_exon_variant | Exon 1 of 4 | 2 | ENSP00000421342.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152148Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000899 AC: 13AN: 1445468Hom.: 0 Cov.: 35 AF XY: 0.00000834 AC XY: 6AN XY: 719516
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152148Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74322
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.206A>G (p.Y69C) alteration is located in exon 1 (coding exon 1) of the SRD5A1 gene. This alteration results from a A to G substitution at nucleotide position 206, causing the tyrosine (Y) at amino acid position 69 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at